These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14648662)

  • 1. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
    Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
    J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
    Nakayama K; Rahman MT; Rahman M; Nakamura K; Ishikawa M; Katagiri H; Sato E; Ishibashi T; Iida K; Ishikawa N; Kyo S
    Int J Oncol; 2016 Feb; 48(2):506-16. PubMed ID: 26647729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations associated with cyclin D1 overexpression in endometrial cancer.
    Moreno-Bueno G; Rodríguez-Perales S; Sánchez-Estévez C; Marcos R; Hardisson D; Cigudosa JC; Palacios J
    Int J Cancer; 2004 Jun; 110(2):194-200. PubMed ID: 15069681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hCDC4 gene mutations in endometrial cancer.
    Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI
    Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
    Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
    Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.
    Moreno-Bueno G; Sánchez-Estévez C; Cassia R; Rodríguez-Perales S; Díaz-Uriarte R; Domínguez O; Hardisson D; Andujar M; Prat J; Matias-Guiu X; Cigudosa JC; Palacios J
    Cancer Res; 2003 Sep; 63(18):5697-702. PubMed ID: 14522886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
    Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
    Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the hCDC4 gene in gastric carcinomas.
    Lee JW; Soung YH; Kim HJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Eur J Cancer; 2006 Sep; 42(14):2369-73. PubMed ID: 16824748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
    Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
    Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
    Moreno-Bueno G; Hardisson D; Sarrió D; Sánchez C; Cassia R; Prat J; Herman JG; Esteller M; Matías-Guiu X; Palacios J
    J Pathol; 2003 Apr; 199(4):471-8. PubMed ID: 12635138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of hCDC4 can cause chromosomal instability.
    Rajagopalan H; Jallepalli PV; Rago C; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C
    Nature; 2004 Mar; 428(6978):77-81. PubMed ID: 14999283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
    Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
    Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient.
    Husdal A; Bukholm G; Bukholm IR
    Cell Oncol; 2006; 28(3):107-16. PubMed ID: 16823179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin E dysregulation and chromosomal instability in endometrial cancer.
    Hubalek MM; Widschwendter A; Erdel M; Gschwendtner A; Fiegl HM; Müller HM; Goebel G; Mueller-Holzner E; Marth C; Spruck CH; Reed SI; Widschwendter M
    Oncogene; 2004 May; 23(23):4187-92. PubMed ID: 15048079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hCDC4 variation in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL
    Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E overexpression and amplification in human tumours.
    Schraml P; Bucher C; Bissig H; Nocito A; Haas P; Wilber K; Seelig S; Kononen J; Mihatsch MJ; Dirnhofer S; Sauter G
    J Pathol; 2003 Jul; 200(3):375-82. PubMed ID: 12845634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms.
    van Drogen F; Sangfelt O; Malyukova A; Matskova L; Yeh E; Means AR; Reed SI
    Mol Cell; 2006 Jul; 23(1):37-48. PubMed ID: 16818231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer.
    Noske A; Brandt S; Valtcheva N; Wagner U; Zhong Q; Bellini E; Fink D; Obermann EC; Moch H; Wild PJ
    Oncotarget; 2017 Feb; 8(9):14794-14805. PubMed ID: 27582547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.